Introduction Human papillomavirus (HPV) testing as the primary cervical cancer screening
method is implemented in several countries. We report data from the first round of a large …

Background Human papillomavirus (HPV) testing is increasingly used as the primary
cervical cancer screening test. In a large pilot implementation, we compared participation …

Background Randomised controlled trials showed human papillomavirus (HPV)-based
screening leads to a significant reduction in cervical cancer incidence compared with …

Introduction In randomized studies, testing for high‐risk (HR) human papillomavirus (hrHPV)
has been more sensitive than conventional cytology in detecting cervical intraepithelial …

Background Screening for cervical cancer based on testing for human papillomavirus (HPV)
increases the sensitivity of detection of high-grade (grade 2 or 3) cervical intraepithelial …

Six European, randomized, controlled trials that will compare human papillomavirus (HPV)
testing with cytological testing for cervical screening are under way. We reviewed the results …

Background In 2017, the Dutch cervical cancer screening program had replaced the primary
cytology-based screening with primary high-risk human papillomavirus-based screening …

Introduction Since 2012, cervical cancer screening has been conducted with a primary high‐
risk human papillomavirus (hrHPV) test and conventional cytology triage in the city of …

Background Cytology-based screening has been a cornerstone of cervical cancer
prevention for decades. Following extensive evidence demonstrating higher sensitivity and …

Our objective was to assess the sensitivity and specificity of human papillomavirus (HPV)
testing for cervical cancer screening in randomized trials. We conducted a systematic …